HPV and Post-Treatment Surveillance

What is the Purpose of this Study?

The purpose of this study is to examine the association between high-risk human papillomavirus (hr-HPV) with cancer recurrence among women who have completed treatment for invasive cervical cancer. Participants will be asked to complete a survey about their demographics and quality of life. They will also be asked to collect a sample using a self-sampling device and complete a survey about their experience participating in hr-HPV self-sampling and the acceptability of post-treatment HPV vaccination. Through this study, researchers aim to better understand the reoccurrence of invasive cervical cancer, in addition to determining whether the self-sample collection device is a good method for sample collection at home and is preferable to having samples collected by physicians in clinic.


Eligibility

Not Available


Where can I participate?

CS Cancer at Cedars-Sinai Medical Center


What is the full name of this clinical trial?

STUDY00002020: HPV and Post-Treatment Surveillance

Study Details
Disease Type/Condition

Cervix

Principal Investigator

Datta, Geetanjali

Co-Investigators

Bobbie Jo Rimel, Eric Vail

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

STUDY00002020


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Cervix

Principal Investigator

Datta, Geetanjali

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

IIT2023-20-DATTA-SURV


Contact
Email
clinicaltrials@cshs.org